4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-14-017982
CIK 0001009356operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:55 PM ET
Size
9.2 KB
Accession
0001209191-14-017982
Insider Transaction Report
Form 4
CHAPPELL JOHN F
Director
Transactions
- Gift
Common Stock
2014-03-05−240→ 460,594 total - Sale
Common Stock
2014-03-04$112.20/sh−10,000$1,122,000→ 460,834 total
Holdings
- 8,200(indirect: By Spouse)
Common Stock
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying) - 50,000(indirect: By GRAT)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.03 to $112.36, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:55 PM ET
- Size
- 9.2 KB